Yield10 Bioscience announces advances in the production of PHA directly in Camelina seeds

Type of post: NEWS IN BRIEF.

Yield10 Bioscience has announced recent advances in the development of Camelina as a platform for the production of PHA (polyhydroxyalkanoates) bioplastics directly in the seed.

Figure 1. Yield10 Bioscience announces advances in the production of PHA directly in Camelina seeds

Those advancements include:
- 2021 Field Test results: In 2021 Yield10 tested the two prototype PHA (C3014 and C3015) producing spring Camelina lines at sites in the U.S. and Canada. Results showed that C3015 lines produced PHA at the 6 percent level as measured as a percent of seed weight, consistent with results observed in field tests conducted in 2020.
- 2022 Seed Scale up Plan: Field work completed during 2021 supports the Yield10’s decision to begin seed scale up of prototype PHA spring Camelina lines. Permitting is underway to plant PHA (C3015) Camelina line at acre-scale this year. This will enable production of PHA for process development and product sampling.
- Development of winter PHA Camelina lines: Yield10 has recently developed winter Camelina varieties containing the PHA (C3014 and C3015) trait. The first field planting of these lines is planned for winter 2022/2023. 
- Ongoing Second-Generation R&D Program: Yield10’s ongoing second-generation research and development program is focused on improving the level of PHA in the seed of Camelina to 10-20 percent. In addition, work is underway to create PHA pathways that enable the production of PHA co-polymers in Camelina. The successful production of PHA co-polymers would expand the range of properties available for PHA produced in Camelina resulting in broader target applications.

Popular Posts

Fotobiorreactores

Hidrotratamiento (HVO) – Conceptos, materias primas y especificaciones

Biobased polyolefins - Biobased Polyethylene (bio-PE)

New HVO plant enters into operation in China

Biorefinery platforms – Sugars